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ABSTRACT 
 Dual screen-printed carbon electrodes modified with 4-carboxyphenyl-
functionalized double-walled carbon nanotubes (HOOC-Phe-DWCNTs/SPCEs) have 
been used as scaffolds for the preparation of electrochemical immunosensors for the 
simultaneous determination of  the cytokines Interleukin-1β (IL-1β) and factor necrosis 
tumor α (TNF-α). IL-1β. Capture antibodies were immobilized onto HOOC-Phe-
DWCNTs/ SPCEs in an oriented form making using the commercial polymeric coating 
Mix&Go™. Sandwich type immunoassays with amperometric signal amplification 
through the use of poly-HRP-streptavidin conjugates and H2O2 as HRP substrate and 
hydroquinone as redox mediator were implemented. Upon optimization of the 
experimental variables affecting the immunosensor performance, the dual 
immunosensor allows ranges of linearity extending between 0.5 and 100 pg/mL and 
from 1 to 200 pg/mL for IL-1β and TNF-α, respectively, these ranges being adequate 
for the determination of the cytokines in clinical samples. The achieved limits of 
detection were 0.38 pg/mL (IL-1β) and 0.85 pg/mL (TNF-α). In addition, the dual 
immunosensor exhibits excellent reproducibility of the measurements, storage stability 
of the anti-IL-Phe-DWCNTs/SPCE and anti-TNF-Phe-DWCNTs/SPCE conjugates, and 
selectivity as well as negligible cross-talking. The dual immunosensor was applied to 
the simultaneous determination of IL-1β and TNF-α in human serum spiked at clinically 
relevant concentration levels and in real saliva samples. 
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1. Introduction  
 Cytokine detection is important for prognosis and diagnosis of different diseases 
related with inflammation, immunology, atherosclerosis and cancer [1]. However, 
monitoring of these proteins show some challenges related to their low concentration 
ranges in biological samples [2], which makes it difficult obtaining accurate and reliable 
analytical results. Moreover, as cytokines are known to work in concert to operate on 
the network of effectors [1] efficient analytical strategies should be implemented in the 
form of multiplexed detection [3]. It is well known that multianalyte approaches provide 
more information for each single sample and lead to faster and low-cost assays.  
 In this paper, we report the construction and analytical performance of an 
electrochemical platform for the simultaneous detection of two important cytokines: 
Interleukin-1β (IL-1β) and factor necrosis tumor α (TNF-α). IL-1β is a pro-
inflammatory cytokine produced by a variety of cells including pancreatic cells, 
adipocytes or macrophages. Similar to other cytokines, the determination of IL-1β is 
relevant for monitoring inflammatory and immune processes, but it is also significant in 
some specific cases. For instance, elevation of the IL-1β concentration is a typical 
reaction of the brain to acute injury and it can be found in a number of chronic 
neurodegenerative diseases such as Alzheimer [4]. In addition, high glucose 
concentrations induce the pancreatic expression of IL-1β leading to alteration of insulin 
secretion, as well as a decrease in cellular proliferation and apoptosis of pancreatic beta 
cells. On the other hand, the role of TNF-α is critical in many diseases including 
rheumatoid arthritis [5] or cancer [6].  
 Biological activities of IL-1β and TNF-α, have been reported to be synergistic 
and overlapping [7]. For instance, both proteins exert an important inhibitory function 
on erythropoiesis blunting the endogenous production of EPO, and might play a role in 
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the pathogenesis of anemia of chronic disorders or that of cancer patients which respond 
to recombinant EPO [8]. Moreover, increased IL-1β and TNF-α levels in vitreous 
humor and serum of patients with proliferative diabetic retinopathy has also been 
described [9]. Elevated levels of various cytokines, including IL-1β and TNF-α, have 
also been identified in the circulation of traumatic brain injury (TBI) patients within 
hours of injury [10]. Interestingly, both proteins can be used as biomarkers to predict 
side effects of cancer therapy such as inflammatory oral mucositis [11]. In addition, 
determination of salivary contents of both cytokines in patients with leukoplakia and 
oral cancer has a great interest [12] and very recently they have also been considered as 
novel biomarkers for the detection of periodontal diseases [13]. 
 Due to the normal levels of IL-1β and TNF-α in biological fluids are in the 
concentration range of few pg/mL, sufficient sensitivity is a requirement for the 
developed analytical methods. Therefore, enhancement in sensitivity has been a 
common issue for the previously reported electrochemical immunosensors. As Table 1 
shows [14-30], the number of sensors described for TNF-α is relatively high whereas 
those for IL-β1 are very scarce. Diverse electrode modifiers [15,16], signal amplifiers 
[16,17] and a variety of electrochemical techniques [18,19] have been employed to 
attain the required detection limits. Regarding the simultaneous determination of these 
cytokines, only three electrochemical immunoassay configurations have been reported 
(Table 1). An ultrasensitive microfluidic array was developed for TNF-α, IL-6, IL-1β, 
and C-reactive protein to assess oral mucositis risk in cancer patients. Magnetic beads 
were used to capture the analytes from serum and detected with a sensor array coated 
with gold nanoparticles and antibodies [11]. A fully integrated BioMEMS was also 
developed to simultaneously detect various  interleukins (IL-1, IL-10, and IL-6) [3]. 
Electrochemical impedance spectroscopy was also used to determine TNF-α and IL-12 
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with limits of detection of 60 and 3.4 pg/mL, respectively, by conjugation of antibodies 
to gold nanoparticles through self-assembled monolayers of 16-mercaptohexadecanoic 
acid [20]. It is worth to mention that commercial ELISA kits for the single 
determination of IL-1β or TNF-α are available but they are characterized by the long 
assay times required and the relatively large sample volumes.  
 The immunosensor described in this work for the simultaneous determination of 
IL-β1 and TNF-α involves the use of dual screen-printed carbon electrodes (SPCEs) 
modified with 4-carboxyphenyl-functionalized double-walled carbon nanotubes 
(HOOC-Phe-DWCNTs) as electrochemical scaffolds for immobilization of the specific 
anti-IL-1β and anti-TNF-α antibodies. As it is known, that DWCNTs possess several 
beneficial properties with respect to MWCNTs for the preparation of electrochemical 
biosensors such as improved lifetimes and high stability under chemical, mechanical 
and thermal treatments [31]. Moreover, DWCNTs provide  better electrochemical 
behavior than SWCNTs enhancing electron transfer and allowing significant 
overpotential reduction for various species. Furthermore, they show a higher reactivity, 
probably as a consequence of the larger number of lattice defects in DWCNTs [32]. 
Furthermore, upon chemical modification of DWCNTs, the outer cylinder acts as a 
protective sheath that preserves the electronic properties of the inner tube [41]. 
Therefore, covalent sidewall chemistry can be performed onto DWCNTs without loss of 
the intrinsic properties [33].  
 Capture antibodies were immobilized onto HOOC-Phe-DWCNTs/SPCEs in an 
oriented form making using the commercial polymeric coating Mix&Go™. This 
polymer contains several metallic complexes with a high efficiency to bind proteins 
[34]. Sandwich type immunoassays with signal amplification through the use of poly-
HRP-streptavidin conjugates were performed for each cytokine. This simple and 
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relatively low cost immunosensor configuration allowed the development of a sensitive 
method for the simultaneous determination of IL-β1 and TNF-α exhibiting improved 
overall analytical performance with respect to previously reported data.  In addition and 
in order to demonstrate the analytical usefulness of the developed methodology, the 
dual immunosensor was applied to the determination of both proteins in human serum 
and saliva.  
 
2. Experimental 
2.1. Reagents and solutions 
 Mouse TNFα capture antibody (anti-TNF), biotinylated goat TNFα detection 
antibody (biotin–anti–TNF), mouse IL1β capture antibody (anti-IL), and biotinylated 
goat ILβ1 detection antibody (biotin-anti-IL) were used. These immunoreagents as well 
as human TNFα and ILβ1 proteins were those included in the DuoSet® ELISA 
Development Systems DY201-05 (ILβ1), and DY210–05 (TNFα)  from R&D Systems. 
Solutions of the respective capture antibodies at a concentration level of 240 μg/mL 
were prepared by dissolving the product in 500 μL PBS. Working solutions were 
prepared by dilution into a 25 mM buffer solution of 2–(N–morpholino) ethanesulfonic 
acid (MES, Gerbu) of pH 5.0. Solutions of the respective detection antibodies at 18 
µg/mL (TNFα)  or 12 µg/mL (ILβ1) concentrations were prepared by dissolving the 
product in 1 mL PBS and 1% BSA. Phosphate buffer saline solution (PBS) consisted of 
a 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, and 1.5 mM KH2PO4 solution of pH 
7.4. 
 Streptavidin labeled with horseradish peroxidase (HRP-Strept, Roche), poly-
HRP-Strept (85-R200) conjugate (Fitzerald), poly-HRP–Strept (S2438) conjugate 
(Sigma), and HRP–Strept–AuNPs (Nanovex Biotechnologies) were tested. Solutions 
7 
 
from each conjugate at the working concentration were prepared in PBS. Double-walled 
carbon nanotubes functionalized with p–aminobenzoic acid (HOOC-Phe-DWCNTs) 
were provided by Instituto de Nanociencia, Nanotecnología y Materiales Moleculares 
(INAMOL) de la Universidad de Castilla La Mancha (Toledo), Mix&Go
™
 polymer was 
from Anteo Diagnostics. Hydroquinone (HQ) and hydrogen peroxide (30%, w/v) were 
from Sigma. Bovine serum albumin (BSA) was from GERBU Biotechnik, GmbH. 
Blocker
®
 Casein in PBS was from Thermo Fisher. Adiponectin (APN, Abcam), 
ceruloplasmin (Cp, Abcam), ghrelin (GHRL, Anaspec) bovine serum albumin (BSA, 
Gerbu), cholesterol (Chol, Sigma), transforming growth factor β1 (TGF β1, R&D 
Systems), hemoglobin (Hb, Sigma), C-reactive protein (CRP, Fitzgerald), interleukin 6 
(IL-6, Abcam), interleukin 8 (IL-8, Abcam), bilirubin (BIL, Aldrich), and leptin (Lep, 
R&D Systems) were tested  as potential interfering compounds. Deionized water was 
from a Millipore Milli-Q purification system (18.2MΩ cm at 25 ºC). 
 
2.2. Apparatus and electrodes 
 All electrochemical measurements were carried out with a potenciostat from 
INBEA Biosensores S.L. equipped with the IbGraph software. Screen-printed carbon 
electrodes (SPCEs, 110 DRP,  4 mm), and dual SPCEs (C 1110 DRP) consisted of two 
elliptic carbon working electrodes with surface area of 5.6 mm
2
, were from DropSens 
(Oviedo, Spain). These electrodes include a carbon counter electrode and a silver 
pseudo-reference electrode. An Elmasonic S–60 (Elma) ultrasonic bath, a Gyrozen 416 
centrifuge (Controltechnica Instruments), and a Vortex homogenizator (Velp 
Scientifica) were also used. pH measurements were performed using a Crison Basic 20+ 
pH–meter. All experiments were performed at room temperature. 
2.3. Samples 
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 The samples analyzed were lyophilized human serum (S2257, Sigma) spiked 
with 2.5, 5 and 7.5 pg/mL IL-1β and 5, 10 and 15 pg/mL TNF-α, and saliva samples 
obtained from two lab researcher (male smoker and female nonsmoker volunteers) and 
collected using a Salivette® collection device (Sarstedt).  
2.4. Procedures 
2.4.1. Preparation of the immunosensors  
 A homogeneous dispersion of HOOC–Phe–DWCNTs was prepared by 
suspending 1 mg of the product in 2 mL distilled water, addition of 27.4 μL of Tween® 
20, and ultrasonic stirring for 60 minutes. Thereafter, modification of the electrodes was 
made by casting 0.5 μL of the HOOC–Phe–DWCNTs dispersion onto the electrode 
surface and allowing drying under IR radiation. This procedure was repeated until a 
total dispersion volume of 1.5 µL was deposited.  Next, 2.5 μL of  Mix&Go solution 
were added and incubated for 60 min. Thereafter, the modified electrode was rinsed 
with water and allowed drying. This washing was accomplished after each electrode 
modification once incubation was made. Then, the corresponding capture antibody 
(anti–IL or anti-TNF) was immobilized by casting 2.5 μL of 4 μg/mL solution of each 
antibody and incubating for 60 min. Blocking with 2.5μL of a 2% BSA solution in PBS 
for 30 min was then made to minimize unspecific interactions. Thereafter, 2.5 μL of the 
antigen (IL-β1 and/or TNF-α) standard solution or the sample were added and incubated 
for 60 min. Next, 2.5 μL of 0.5 μg/mL biotinylated antibody solution (Biotin–anti–IL or 
Biotin-anti-TNF) were added and incubated for 45 min. Finally, 2.5 μL of a 1/500 
diluted poly–HRP–Strept solution were dropped on the modified electrode allowing 
incubation for 15 min. 
2.4.2. Simultaneous determination of  IL-β1 and TNF-α 
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 The determination of both cytokines was accomplished by dropping 45 μL of a 1 
mM HQ solution onto the surfaces of the dual SPCE immunosensor horizontally 
positioned and applying a detection potential of -0.20 V. Once the background current 
was stabilized (approx.100 s), 5 mL of a 50 mM  H2O2 solution was added and allowed 
standing for 200 s. The steady state current corresponding to the electrochemical 
reduction of benzoquinone was used as the analytical readout. 
2.4.3. Samples analysis 
 Lyophilized serum was firstly reconstituted by dissolving 370 mg in 5 mL of 
deionized water mixing with gentle stirring. Then, the serum was spiked with 2.5, 5 or 
7.5 pg/mL IL-1β and 5, 10 or 15 pg/mL TNF-α, and the determination of both proteins 
was performed by application of the procedures 2.4.1 and 2.4.2. and interpolation of the 
amperometric responses in the respective calibration plot constructed with standard 
solutions. 
 Regarding saliva, samples were collected from the volunteers after rinsing the 
mouth thoroughly with water and chewing a cotton swab for 5 min. Then, the swap 
saturated with saliva was inserted into a vial, sealed with the cap and centrifuged for 10 
min at 3000 x g. The determination was performed immediately by applying the 
procedure described above using 5-μL aliquots of the undiluted sample. 
 
3. Results and discussion 
 The methodologies employed in this work involved the immobilization of 
capture antibodies onto SPCEs modified with 4-carboxyphenyl-functionalized double-
walled carbon nanotubes (HOOC-Phe-DWCNTs) and application of sandwich type 
immunoassays for each cytokine with signal amplification through the use of poly-
HRP-streptavidin conjugates. These strategies took advantage of: i) the well-known 
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enhancement of electron transfer processes occurring on DWCNTs-modified electrode 
surfaces, ii) the high availability of surface confined carboxyl groups onto HOOC-Phe-
DWCNTs, iii) the oriented immobilization of antibodies by means of Mix&Go polymer, 
and iv) the amplification of the electrochemical responses with poly-HRP-Strept.   
 The protocols used for the preparation of the dual immunosensor are described 
in the Experimental section and schematically displayed in Figure 1. Once Mix&Go 
was dropped onto each surface of HOOC-Phe-DWCNTs-modified dual SPCE, anti-IL 
and anti-TNF antibodies were immobilized and a subsequent blocking step of the 
remaining active free sites on the electrode surfaces was carried out. Then, sandwich 
type assays involving the target cytokines and biotinylated detector antibodies were 
accomplished. A further conjugation with poly-HRP-Strept allowed the amperometric 
determination of IL-1β and TNF-α to be performed using H2O2 as HRP substrate and 
hydroquinone (HQ) as the redox mediator.   
 
SPCE
HOOC-Phe-DWCNTs
M&G
a) 
b) 
Mix&Go anti-TNF anti-IL TNF-α IL-1β biotin-anti-TNF biotin-anti-IL poly-HRP-StreptBSA
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Figure 1. Schematic display of the different steps involved in the preparation of the 
dual electrochemical immunosensor for multiplexed determination of IL-1β and TNF-α 
cytokines. 
 
3.1. Optimization of the experimental variables involved in the preparation of the 
dual immunosensor 
 Variables involved in the preparation of the dual immunosensor for the 
simultaneous determination of IL-1β and TNF-α were optimized. These studies were 
performed individually for each cytokine using single modified-SPCEs and included: a) 
the antibody (anti-IL or anti-TNF) loading onto HOOC-Phe-DWCNTs/SPCE and the 
time for incubation; b) the Biotin-antibody loading onto IL-1β-anti-IL-Phe-DWCNTs/ 
SPCE or TNF-α-anti-TNF-Phe-DWCNTs/SPCE and the time for incubation; c) the 
blocking step, and d) the type of enzyme label and the loading of poly-HRP-Strept onto 
Biotin-anti-IL-IL1β-anti-IL-Phe-DWCNTs/SPCE or Biotin-anti-TNF-TNF-α-anti-TNF-
Phe-DWCNTs/SPCE. Other variables involved in the preparation of the modified 
electrodes such as the loading of HOOC-Phe-DWCNTs onto SPCE and the loading of 
Mix&Go onto HOOC-Phe-DWCNTs/SPCE, as well as those implied in the 
electrochemical detection such as the detection potential value or the concentration of  
H2O2 and HQ were the same than those employed in previous papers [35, 36 45, 46]. 
Details on these optimization studies are provided in Supplementary material and 
Figures S1-S4 and summarized in Table 2.    
 
3.2. Analytical characteristics of the dual immunosensor 
 The calibration plots for IL-1β and TNF-α constructed with the dual 
immunosensor under the optimized working conditions are shown in Figure 2. Error 
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bars were calculated from the measurements carried out with three different dual 
immunosensors for each concentration. The steady state current vs. IL-1β concentration 
(Figure 2a) followed the adjusted equation I, nA = (624 ± 15) log C, pg/mL + 393 ± 18 
(r
2
 = 0.996), with a range of linearity extending between 0.5 and 100 pg/mL IL-1β. 
Figure 2b displays the calibration plot for TNF-α with an equation I, nA = (746 ± 16) 
log C, pg/mL + (245 ± 22)  (r
2
 = 0.999), with a range of linearity from 1 to 200 pg/mL. 
It is worth to mention that these ranges, covering two orders of magnitude, are adequate 
for the determination of the cytokines in clinical samples taking into account the 
expected concentrations at the level of few pg/mL [19]. The achieved limits of detection 
were 0.38 pg/mL (IL-1β) and 0.85 pg/mL (TNF-α) and were calculated by using the 3sb 
criterion, where sb was estimated as the standard deviation expressed in concentration 
units (n =10) of the measured currents for the blank (0 pg/mL IL-1β or TNF-α).  
 
 
Figure 2. Calibration plots for IL-1β (green) and TNF-α (blue) obtained with the dual 
poly-HRP-Strept-Biotin-anti-IL-IL1β-anti-IL-Phe-DWCNTs/SPCE and poly-HRP-
Strept-Biotin-anti-TNF-TNF-α-anti-TNF-Phe-DWCNTs/SPCE immunosensor. See text 
for other conditions. 
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 When these analytical characteristics are compared with those reported for other 
electrochemical immunosensors (Table 1), it can be concluded that the developed 
methodology can be ranked among the most sensitive exhibiting low detection limits 
and linear ranges covering low concentration ranges. It should also be remarked that this 
excellent analytical performance is accompanied by a relatively short time of analysis. 
In fact, the whole experimental procedure, once the capture antibodies are immobilized, 
took 2h 30 min. This period is much shorter than that required when commercial ELISA 
kits for IL-1β or TNF-α are employed. For example, the assays with the DuoSet® 
ELISA from R&D Systems [www.rndsystems.com] last 4h 40 min. 
 The reproducibility of the measurements was tested with different dual 
immunosensors prepared on the same day and on different days, and in the absence or 
in the presence of 50 pg/mL IL-1β or 100 pg/mL TNF-α. The relative standard 
deviation (RSD) values obtained were 0.6 and 2.7 % (IL-1β) (n=4), and 0.3 and 0.7 % 
(TNF-α) (n=5), respectively, for the assays performed on the same day, and 0.8 % and 
3.7 % (IL-1β) (n=4), and 0.5 and 0.7 % (TNF-α) (n=5) respectively, for the 
measurements made on different days. These results indicated the good level of 
precision achieved in the fabrication and functioning of the developed dual 
electrochemical immunosensing platform. 
 In addition, the storage stability of the anti-IL-Phe-DWCNTs/SPCE and anti-
TNF-Phe-DWCNTs/SPCE conjugates, once they were blocked with 2% BSA, was 
tested under storage at -20 ºC in a dry environment. Several bioconjugates were 
prepared on the same day, stored, and used to construct on different days,  poly-HRP-
Strept - Biotin - anti - IL - IL1β - anti - IL - Phe - DWCNTs / SPCE and poly - HRP-
Strept-Biotin-anti-TNF-TNF-α-anti-TNF-Phe-DWCNTs/SPCE dual immunosensors. 
The amperometric currents measured for 50 pg/mL IL-1β and 100 pg/mL TNF-α 
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solutions (Figure S5) remained within the control limits set by ± 3 times the standard 
deviation of the measurements (n=3) carried out on the first day, during at least 40 days. 
This excellent storage stability suggests the possibility of preparing a set of anti-IL-Phe-
DWCNTs/SPCE and anti-TNF-Phe-DWCNTs/SPCE conjugates and storing them under 
the above mentioned conditions until their use for the preparation of the immunosensors 
was requested.  
 
3.3. Selectivity studies 
 The effect of potential interfering compounds that may be present together with 
the target cytokines in biological samples on the electrochemical responses obtained 
with the dual immunosensors was studied. As the used antibodies exhibit demonstrated 
specificity for IL-1β or TNF-α against other cytokines such as IL-1α, or TNF-β, TNF-RI 
and TNF-TII, respectively, the compounds tested were: adiponectin (APN), bovine 
serum albumin (BSA), cholesterol (Chol), C-reactive protein (CRP), hemoglobin (Hb), 
interleukin 6 (IL-6), interleukin-8 (IL-8), transforming growth factor β1 (TGF-β1), 
bilirubin (BIL), ceruloplasmin (Cp), ghrelin (GHRL) and leptin (LEP). Figure 3 shows a 
comparison of the amperometric responses obtained with the dual immunosensor for 0 
and 10 pg/mL IL-1β or TNF-α in absence and in the presence of each tested compound 
at their normal concentration levels in human serum. As it is clearly shows, no 
significant effect on the dual electrochemical immunosensor response was apparent in 
the presence of any non-target compound, thus demonstrating the excellent selectivity 
of the proposed configuration for simultaneous IL-1β and TNF-α determination.  
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Figure 3. Effect of the presence of 20 μg/mL APN, 5 mg/mL BSA, 190 ng/mL bilirubin 
(BIL), 20 μg/mL Chol, 500 μg/mL ceruloplasmin (Cp), 500 pg/mL ghrelin (GHRL), 50 
μg/mL Hb, 50 pg/mL IL-6, 30 pg/mL IL–8,  5 ng/mL leptin (Lep),  500 pg/mL TGF–
β1, 100 pg/mL TNF–α (a) or 50 pg/mL IL–1β (b), 1 μg/mL CRP on the amperometric 
responses obtained for 0 (white) and 10 (grey) pg/mL IL-1β (a) or TNF-α (b) at the dual 
electrochemical immunosensor. See the text for more information. 
 
 Moreover, the possible cross-talking between the adjacent working modified 
SPCEs in the dual configuration and reaction products was evaluated by comparing the 
amperometric responses recorded at the poly-HRP-Strept-Biotin-anti-IL-IL1β-anti-IL-
Phe-DWCNTs/SPCE where 10 pg/mL TNF-α were deposited, and at the poly-HRP-
Strept-Biotin-anti-TNF-TNF-α-anti-TNF-Phe-DWCNTs/SPCE with 25 pg/mL IL-1β, 
with those obtained for 0 or 25 pg/mL IL-β1 and 10 pg/mL TNF-α, respectively. Figure 
4 shows clearly that no significant differences in the amperometric responses of 
immunosensors exist in the absence of the non-target antigen, thus demonstrating that 
no appreciable cross-talking occurred with the developed dual immunosensor. 
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Figure 4. Amperometric responses recorded with the dual immunosensor at poly-HRP-
Strept-Biotin-anti-IL-IL1β-anti-IL-Phe-DWCNTs/SPCE for 25 or 0 pg/mL IL-1β 
(green), or 10 pg/mL TNF-α (blue) (a), and at poly-HRP-Strept-Biotin-anti-TNF-TNF-
α-anti-TNF-Phe-DWCNTs/SPCE for with 10 or 0 pg/mL TNF-α (blue), or 25 pg/ mL 
IL-1β (green) (b). See the text for more information. 
 
 
 
3.4. Simultaneous determination of IL-1β and TNF-α in spiked serum and saliva 
 The developed dual immunosensor was applied to the simultaneous 
determination of IL-1β and TGF-β in human serum spiked at clinically relevant 
concentration levels [37, 38] and in real saliva samples. Regarding serum, the possible 
existence of matrix effects was initially evaluated by constructing a calibration plot in 
the sample (lyophilized serum from Sigma) which was spiked with IL-1β over the 2.5 to 
7.5 pg/mL, and with TNF-α over the 5 to 15 pg/mL concentration ranges, respectively. 
The equations obtained for the respective calibration graphs were I, nA = (597 ± 6) log 
C, pg/mL + (400 ± 4), (r
2
=0.9998), and I, nA= (766.3 ± 0.2) logC, pg/mL + (237.8 ± 
0.2), (r
2
=0.9999) for IL-1β and TNF-α, respectively. The comparison of the slope values 
with those calculated for the calibration plots constructed with standard solutions by 
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applying the Student´s t test showed texp values 1.655 (IL-1β) and 1.231 (TNF-α) lower 
than that tabulated t, 2.306, therefore indicating that no statistically significant 
differences existed between the slopes values for both types of calibration plots. 
Therefore, the determination of IL-1β and TNF-α could be carried out by interpolation 
of the current values measured for the serum samples into the calibration plots 
constructed with the standard solutions. Table 3 summarizes the results obtained by 
triplicate analysis of samples spiked at three different concentration levels: 2.5, 5.0 and 
7.5 pg/mL IL-1β and 5. 10 and 15 pg/mL TNF-α.  As it can be seen, recoveries ranged 
between 98 and 104 %,  indicating the reliability of the approach to determine low IL-
1β and TNF-α concentrations in serum following a simple working protocol. 
 Furthermore, two different saliva samples corresponding to a male smoker and a 
female nonsmoker volunteers were analyzed to determine the endogenous content of 
both IL-1β and TNF-α. Considering the complexity of saliva, we also evaluated the 
potential occurrence of matrix effect. A calibration plot was constructed by adding 
known cytokine concentrations between 0.5 and 50 pg/mL for IL-1β and 2 and 40 
pg/mL for TNF-α to saliva from both patients. The respective slope values of the linear 
ranges (630 ± 14 and 627 ± 5 for IL-1β; 745 ± 37 and 758 ± 5 for TNF-α) were 
statistically compared with those calculated from the calibration graphs with IL-1β or 
TNF-α standards.  (624 ± 15 and 746 ± 16 nA per decade of concentration). No 
significant difference for a 95 % confidence interval (texp = 0.27 and 0.17 (IL-1β) and 
0.10 and 0.67 (TNF-α) were lower than ttab = 2.201). Accordingly, the determination of 
IL-1β and TNF-α in saliva was accomplished by interpolation of the measured current 
in the samples into the calibration plot constructed with standard solutions. Table 4 
summarizes the results obtained in the analysis of saliva. Interestingly, the found values 
re consistent with those reported using other approaches [49] and, as expected, no 
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significant differences in salivary concentrations of the cytokines are apparent between 
smoker and non smoker individuals.  
 In addition, the results were compared with those obtained using the DuoSet
®
 
ELISA Development Systems DY201-05 (IL1β), and DY210–05 (TNFα) from R&D 
Systems. The ELISA protocols were similar for both cytokines and, briefly, involved 
incubating the capture antibody solution into the wells overnight at room temperature, 
followed by washing and blocking with BSA for a minimum of 1 h. Then, 100 μL of the 
sample or standards per well were added and incubated 2 h at room temperature. After 
washing, 100 μL of the detection antibody (biotinylated antibody) were added to each 
well and incubated 2 h at room temperature. Once washed, 100 μL of the HRP-Strept 
solution were added to each well leaving for 20 min at room temperature, and color 
development was achieved by the addition of TMB substrate solution. Finally, after 20 
min, an acid “stop solution” was added, and the absorbance was mesured at 450 nM. As 
it can be deduced from Table 4, the results obtained are consistent with those provided 
by the immunosensor. Indeed, the concentration values found by both methods were 
statistically compared by means of the Student’s t test. The texp values,  0.30 and 0.15 
for IL-1β and 0.55 and 0.30 for TNF-α, were lower than the tabulated t value (2.16) and, 
therefore, no significant differences were found between both methodologies at a 
significance level of 0.05. These results demonstrate clearly the usefulness of the 
developed immunosensor to determine simultaneously IL-1β  and TNF-α at clinically 
relevant concentrations in biological fluids such as serum or saliva.  
 
4. Conclusions 
 An electrochemical dual platform for the simultaneous determination of IL-β1 
and TNF-α cytokines is reported in this work. The platform profits the benefits inherent 
to electrode modification with 4-carboxyphenyl-functionalized double-walled carbon 
19 
 
nanotubes  where specific anti-IL-1β and anti-TNF-α antibodies were immobilized in an 
oriented manner using the commercial polymeric coating Mix&Go™. Sandwich type 
immunoassays with signal amplification by means of poly-HRP-streptavidin conjugates 
allowed the development of a sensitive method for the simultaneous determination of 
IL-β1 and TNF-α with improved analytical performance with respect to previously 
reported approaches and commercial ELISA kits. The dual immunosensor was 
successfully applied to the determination of both cytokines at clinically relevant 
concentrations in biological fluids such as serum or saliva. In this context, an important 
point to be remarked is the simultaneous assay takes about 2h 30 min once the capture 
antibodies were immobilized. Conversely, ELISAs require 4h 40 min for each 
determination. Moreover, the reagents consumption is much lower in the method using 
the dual immunosensor since it only requires 2.5 μL each time while 100 μL of the same 
reagents are needed in the ELISA protocol. 
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